USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 144 filers reported holding USANA HEALTH SCIENCES INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $22,000 | -96.5% | 219 | -96.6% | 0.00% | -100.0% |
Q1 2021 | $627,000 | +26.7% | 6,425 | 0.0% | 0.00% | +33.3% |
Q4 2020 | $495,000 | +4.7% | 6,425 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $473,000 | -5.6% | 6,425 | -5.9% | 0.00% | 0.0% |
Q2 2020 | $501,000 | +17.3% | 6,831 | -7.9% | 0.00% | 0.0% |
Q1 2020 | $427,000 | -44.0% | 7,415 | -23.6% | 0.00% | 0.0% |
Q4 2019 | $762,000 | -54.1% | 9,705 | -60.0% | 0.00% | -62.5% |
Q3 2019 | $1,661,000 | -14.8% | 24,288 | -1.0% | 0.01% | -11.1% |
Q2 2019 | $1,949,000 | -35.7% | 24,536 | -32.1% | 0.01% | -30.8% |
Q1 2019 | $3,032,000 | -36.1% | 36,148 | -10.4% | 0.01% | -40.9% |
Q4 2018 | $4,747,000 | -16.6% | 40,324 | -14.6% | 0.02% | +4.8% |
Q3 2018 | $5,690,000 | +166.0% | 47,199 | +154.4% | 0.02% | +162.5% |
Q2 2018 | $2,139,000 | +3525.4% | 18,551 | +1907.7% | 0.01% | – |
Q2 2017 | $59,000 | +126.9% | 924 | +102.6% | 0.00% | – |
Q1 2017 | $26,000 | -97.5% | 456 | -97.4% | 0.00% | -100.0% |
Q4 2016 | $1,060,000 | -14.6% | 17,328 | +93.2% | 0.01% | -16.7% |
Q3 2016 | $1,241,000 | -37.2% | 8,967 | -49.5% | 0.01% | -40.0% |
Q2 2016 | $1,977,000 | -38.1% | 17,744 | -32.5% | 0.01% | -37.5% |
Q1 2016 | $3,193,000 | -59.7% | 26,295 | -57.6% | 0.02% | -59.0% |
Q4 2015 | $7,927,000 | -0.2% | 62,050 | +4.7% | 0.04% | -7.1% |
Q3 2015 | $7,945,000 | +18.8% | 59,274 | +21.1% | 0.04% | +23.5% |
Q2 2015 | $6,690,000 | +159.6% | 48,957 | +111.1% | 0.03% | +161.5% |
Q1 2015 | $2,577,000 | +8.3% | 23,195 | 0.0% | 0.01% | +8.3% |
Q4 2014 | $2,380,000 | -27.8% | 23,195 | -48.2% | 0.01% | -25.0% |
Q3 2014 | $3,297,000 | +35.3% | 44,753 | +43.6% | 0.02% | +33.3% |
Q2 2014 | $2,436,000 | +910.8% | 31,171 | +874.4% | 0.01% | +1100.0% |
Q1 2014 | $241,000 | -46.9% | 3,199 | -46.7% | 0.00% | -50.0% |
Q4 2013 | $454,000 | -17.3% | 6,004 | -5.2% | 0.00% | -33.3% |
Q3 2013 | $549,000 | +134.6% | 6,331 | +95.7% | 0.00% | +200.0% |
Q2 2013 | $234,000 | – | 3,235 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
RQSI Ltd | 3,937 | $404,000 | 0.38% |
CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |